Article

STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder…

International Journal of General Medicine · 2021 · Sun J, Wei X, You J, Yue W, Ouyang J, Ling Z, Hou J

Key facts

Title STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer
First author Sun J, Wei X, You J, Yue W, Ouyang J, Ling Z, Hou J
Journal International Journal of General Medicine
Published Sep 11, 2021
DOI 10.2147/IJGM.S329723
Devices mentioned 215006, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature